CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 4 Open-market buy PRESIDENT AND CEO bought 26,065 shares at $3.83 ($99,829)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise EVP & CHIEF INNOVATION OFFICER acquired 30,646 shares (option exercise)
- 4 Open-market buy Director bought 613,497 shares at $5.41 ($3,319,019)
- 4 Open-market buy Director bought 8,000 shares at $5.78 ($46,240)
- 4 Open-market buy Director bought 8,000 shares at $6.20 ($49,600)
- 4 Open-market buy Director bought 8,000 shares at $5.67 ($45,360)
- 4 Open-market sale CHIEF MEDICAL OFFICER sold 5,820 shares at $5.43 ($31,603)
- 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 4,339 shares at $5.42 ($23,517)
- 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 5,566 shares at $5.42 ($30,168)
- 4 Open-market sale EVP & CHIEF SCIENTIFIC OFFICER sold 5,894 shares at $5.43 ($32,004)
- 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 5,565 shares at $5.42 ($30,162)
- 4 Derivatives Options or other derivatives
Page 1 of 11 · 206 filings